标题
New molecular insights into osteosarcoma targeted therapy
作者
关键词
-
出版物
CURRENT OPINION IN ONCOLOGY
Volume 25, Issue 4, Pages 398-406
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-05-10
DOI
10.1097/cco.0b013e3283622c1b
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recurrent RECQL4 Imbalance and Increased Gene Expression Levels Are Associated with Structural Chromosomal Instability in Sporadic Osteosarcoma
- (2015) Georges Maire et al. NEOPLASIA
- APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival
- (2014) Jilong Yang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells
- (2012) Zan Chen et al. ACTA PHARMACOLOGICA SINICA
- Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
- (2012) Kristiaan Lenos et al. CANCER RESEARCH
- miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
- (2012) K. B. Jones et al. CANCER RESEARCH
- Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling
- (2012) Yonggang Li et al. FEBS Journal
- Exploration of a new drug that targets YAP
- (2012) M. Fujii JOURNAL OF BIOCHEMISTRY
- HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis
- (2012) Dan Liang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway
- (2012) Annamaria Spina et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3
- (2011) Li-hong Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, includingVEGFA, in human osteosarcoma
- (2011) Jilong Yang et al. CANCER
- Cell surface receptor expression patterns in osteosarcoma
- (2011) Sheref E. Hassan et al. CANCER
- Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo
- (2011) Jiro Ichikawa et al. CANCER
- Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma
- (2011) Takanao Sueyoshi et al. CANCER LETTERS
- HMGB1 Promotes Drug Resistance in Osteosarcoma
- (2011) J. Huang et al. CANCER RESEARCH
- P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma
- (2011) Daria Brambilla et al. INTERNATIONAL JOURNAL OF CANCER
- A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription
- (2011) Y. Bao et al. JOURNAL OF BIOCHEMISTRY
- CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis
- (2011) Olivia Fromigue et al. JOURNAL OF BONE AND MINERAL RESEARCH
- MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 Expression
- (2011) Mitsuhiko Osaki et al. MOLECULAR THERAPY
- Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma
- (2010) Yu-Cai Wang et al. ACTA HISTOCHEMICA
- Functional and biological analysis of Bcl-xL expression in human osteosarcoma
- (2010) Zhao-Xia Wang et al. BONE
- High Wnt Signaling Represses the Proapoptotic Proteoglycan syndecan-2 in Osteosarcoma Cells
- (2010) F.-X. Dieudonne et al. CANCER RESEARCH
- Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
- (2010) Bo Song et al. Molecular Cancer
- c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis
- (2010) T Shimizu et al. ONCOGENE
- Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness
- (2010) P Zhang et al. ONCOGENE
- IKK protein is a target of BAG3 regulatory activity in human tumor growth
- (2010) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of the E2F1-Driven Cancer Cell Fate by the DNA Damage Response Machinery and Potential Novel E2F1 Targets in Osteosarcomas
- (2009) Michalis Liontos et al. AMERICAN JOURNAL OF PATHOLOGY
- Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma
- (2009) Jilong Yang et al. CANCER LETTERS
- Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
- (2009) S. Avnet et al. CANCER RESEARCH
- Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
- (2009) Kazuhito Morioka et al. CANCER SCIENCE
- Functional genome screen for therapeutic targets of osteosarcoma
- (2009) Umio Yamaguchi et al. CANCER SCIENCE
- The kinase Mirk is a potential therapeutic target in osteosarcoma
- (2009) C. Yang et al. CARCINOGENESIS
- Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics
- (2009) Annette S. Gillings et al. FEBS Journal
- The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines
- (2009) Jennifer K. McCleese et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2
- (2009) Sébastien Salas et al. INTERNATIONAL JOURNAL OF CANCER
- Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma
- (2009) Yongping Cai et al. JOURNAL OF PATHOLOGY
- Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells
- (2009) Yin-He Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
- (2009) T. Akiyama et al. MOLECULAR CANCER THERAPEUTICS
- Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
- (2009) M Enomoto et al. ONCOGENE
- Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin
- (2009) X Wan et al. ONCOGENE
- Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway
- (2008) T. Akiyama et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search